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Abstract
Cyclosporine A (CsA) is a powerful immunosuppressive drug with side effects including the development of chronic
nephrotoxicity. In this study, we investigated CsA treatment induced apoptotic and autophagic cell death in pituitary GH3
cells. CsA treatment (0.1 to 10 mM) decreased survival of GH3 cells in a dose-dependent manner. Cell viability decreased
significantly with increasing CsA concentrations largely due to an increase in apoptosis, while cell death rates due to
autophagy altered only slightly. Several molecular and morphological features correlated with cell death through these
distinct pathways. At concentrations ranging from 1.0 to 10 mM, CsA induced a dose-dependent increase in expression of
the autophagy markers LC3-I and LC3-II. Immunofluorescence staining revealed markedly increased levels of both LC3 and
lysosomal-associated membrane protein 2 (Lamp2), indicating increases in autophagosomes. At the same CsA doses,
apoptotic cell death was apparent as indicated by nuclear and DNA fragmentation and increased p53 expression. In
apoptotic or autophagic cells, p-ERK levels were highest at 1.0 mM CsA compared to control or other doses. In contrast, Bax
levels in both types of cell death were increased in a dose-dependent manner, while Bcl-2 levels showed dose-dependent
augmentation in autophagy and were decreased in apoptosis. Manganese superoxide dismutase (Mn-SOD) showed a
similar dose-dependent reduction in cells undergoing apoptosis, while levels of the intracellular calcium ion exchange
maker calbindin-D9k were decreased in apoptosis (1.0 to 5 mM CsA), but unchanged in autophagy. In conclusion, these
results suggest that CsA induction of apoptotic or autophagic cell death in rat pituitary GH3 cells depends on the relative
expression of factors and correlates with Bcl-2 and Mn-SOD levels.
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Introduction
Programmed cell death (PCD) can be classified as either type I
or type II PCD, based on distinctive morphological and
biochemical characteristics. Type I PCD, or apoptosis, is
characterized by blebbing, changes to the cell membrane such
as loss of membrane asymmetry and attachment, cell shrinkage,
nuclear fragmentation, chromatin condensation, and the forma-
tion of apoptotic bodies (apoptosomes) [1]. In contrast, type II
PCD, or autophagy, is marked by extensive autophagic degrada-
tion of intracellular organelles, resulting in lysosome-associated
cytoplasmic vacuolation/autophagosome formation [2]. Microtu-
bule-associated protein 1 light chain 3 (LC3) is a marker for the
autophagic process during which it is converted from the cytosolic
form, LC3-I, to LC3-II, a modified form that is localized to
autophagosomal membranes [3].
Currently, there is no known overlap in the pathways that
modulate autophagic and apoptotic cell death [4,5]. However,
apoptotic and autophagic processes may functionally coordinate in
three ways: both apoptosis and autophagy can cooperate to induce
cell death; autophagy can act as an antagonist to block apoptotic
cell death; and autophagy can act as a precursor or even initiator
of apoptosis. Several specific examples of coordination between
autophagy and apoptosis have been documented. The proapop-
totic molecule TRAIL mediates autophagy [6]. In addition,
growth factor deprivation induces an autophagic cell death, which
can be inhibited by the anti-apoptotic factor Bcl-2 [7]. These data
suggest that autophagic cell death may be induced by HSpin1, a
transmembrane protein that interacts with Bcl-2/Bcl-xL [8].
Cyclosporine A (CsA) was first approved by the United States
Food and Drug Administration in the early 1980s, and has been
used significantly in prophylactic anti-rejection therapy for
patients receiving allogeneic transplants (kidney, liver, and heart)
for over two decades [8,9]. However, several side effects of CsA
have been reported in both transplant and non-transplant (i.e.,
individuals with autoimmune disorders) patients, including neph-
rotoxicity, hepatotoxicity, neurotoxicity, hypertension, dyslipide-
mia, gingival hyperplasia, hypertrichosis, malignancies, and an
increased risk of cardiovascular events [10,11]. Recent reports
demonstrate that CsA induces autophagy in vitro in human
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tubular cells and in vivo in rat kidneys, and it has been suggested
that autophagy serves as a protective mechanism against
cyclosporine toxicity [12–14]. Importantly, it has been shown
that cyclosporine-induced autophagy is triggered by endoplasmic
reticulum (ER) stress [15]. Other reports show that CsA can
induce apoptosis in human proximal tubular cells in vitro [16] and
induces apoptosis via prolonged ER stress in an experimental
model of chronic nephropathy [17].
In this study, we investigated whether CsA induces apoptotic
and/or autophagic cell death in rat pituitary GH3 cells and
correlated the levels of several characteristic molecular markers of
these two pathways with cell death outcomes.
Figure 1. Cell viability and LC3 expression following CsA treatment. GH3 cells were incubated in DMEM with and without 10% fetal bovine
serum in the presence or absence of CsA (0 to 10 mM) for 10 h. Cell survival was determined using Cell Counting Kit-8 (A) and LC3 expression was
determined by Western blotting (B) as described in Materials and Methods. Immunofluorescence staining of LC3 and Lamp2 (C, D), DAPI staining (E),
and DNA fragmentation (F) were captured as described in Materials and Methods. E: a, with FBS; b, without FBS; c, 1.0 mM CsA; d, 2.5 mM CsA; e,
5.0 mM CsA; f, 10 mM CsA. Scale bars: C, 100 mm; D, 25 mm; E, 100 mm. ***p,0.001 vs. serum treatment. #p,0.05, ##p,0.01, ###p,0.001 vs. serum
treatment.
doi:10.1371/journal.pone.0108981.g001
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Results
Cell viability and LC3 expression following CsA treatment
Many in vivo and in vitro studies have shown that CsA induces
either autophagy or apoptosis [12–14,16,17]. To further these
studies and examine how CsA concentration alters cell death
pathway fate, we investigated CsA treatment for 10 h at different
CsA doses. For autophagy study, polyethyleneimine was coated on
culture dish. CsA treatment induced apoptotic and autophagic cell
death with distinct toxicities in rat pituitary GH3 cells. CsA
treatment (0.1 to 10 mM) decreased survival of rat pituitary GH3
cells in a dose-dependent manner. Apoptosis resulted in an 87%
decrease in cell viability following treatment with 10 mM CsA,
whereas autophagy resulted in a 30% reduction in cell viability at
the same dose (Fig. 1A). At concentrations ranging from 1.0 to
10 mM, CsA induced a dose-dependent increase in the expression
of LC3-I and LC3-II (Fig. 1B). At 5 mM CsA, immunofluores-
cence staining were performed to detect the co-localization of LC3
and lysosomal-associated membrane protein 2 (Lamp2). The
increased LC3-positive granules or puncta were co-localized with
the increased Lamp2, indicating increases in autophagosomes
(Fig. 1C, D). Together, these data indicate that CsA induces
autophagy in rat pituitary GH3 cells. In parallel, some CsA
concentrations also induced apoptotic cell death in a dose-
dependent manner as assayed by nuclear fragmentation with
DAPI staining (Fig. 1E). In particular, treatment with 2.5 to
10 mM CsA induced clear nuclear and DNA fragmentation
(Fig. 1E, F) and an increase in p53 expression (Fig. 2) compared to
treatment with or without serum. These data indicate that 1.0 to
10 mM CsA can induce dose-dependent autophagy and apoptosis
in GH3 cells.
The differences of molecular levels between apoptosis
and autophagy
Levels of several molecules implicated in PCD pathways were
examined in cells undergoing CsA induced apoptosis or autoph-
agy. In both apoptosis and autophagy, p-ERK levels were highest
following treatment with 1.0 mM CsA and decreased following 2.5
to 10 mM CsA treatment (Fig. 3). In contrast, Bax levels were
altered in a dose-dependent fashion that varied with the cell death
pathway, showing an increase in autophagy (Fig. 4A, B) and
apoptosis (Fig. 4E, F). These changes in p-ERK and Bax levels
demonstrate that CsA toxicity can influence survival of GH3 cells
depending on the CsA dose. Bcl-2 levels increased during
autophagy following treatment with 1.0 and 10 mM CsA as
measured by western blot (Fig. 4A, C) and immunofluorescence
(Fig. 4D), while Bcl-2 levels decreased during apoptosis (Fig. 4E,
G). These data suggest that Bcl-2 protein expression may result in
difference between apoptosis and autophagy by CsA.
The differences of Cu/Zn- and Mn-SOD between
apoptosis and autophagy
CsA-induced nephrotoxicity may result from oxidative stress,
and correspondingly, antioxidant enzymes, including SOD,
catalase, and glutathione peroxidase, were found to be reduced
in CsA related toxicity [18]. To examine these alterations in
relationship to CsA-induced cell death, we assayed the levels of
Cu/Zn- and Mn-SOD. CsA-mediated autophagy resulted in
slightly lower levels of Cu/Zn-SOD expression, while Mn-SOD
expression was relatively unchanged (Fig. 5A–C). In apoptotic
cells, Cu/Zn-SOD expression was increased following 2.5 mM
CsA treatment and higher doses decreased levels to those observed
in the serum free condition (Fig. 5D, E). Mn-SOD expression
showed a dose-dependent reduction (Fig. 5D, F). These results
suggest that a decline in Mn-SOD levels may induce CsA-
mediated apoptotic cell death in GH3 cells.
The difference of calbindin-D9k between apoptosis and
autophagy
In a recent report, Pallet et al. [13,14] found that CsA induces
ER stress in renal tubular cells. Indeed, the ER appears to be an
initiator or a regulator of apoptosis [19]. Stimulation of inositol
1,4,5-triphosphate (IP3) causes Ca2+ release from the ER [20],
which is involved in apoptotic signal transduction and is required
for Ca2+-dependent DNA fragmentation [21]. To examine this
pathway, we assayed the levels of the intracellular Ca2+ modulator
calbindin-D9k. Calbindin-D9k levels were increased in autophagy
compared to the serum-free control (Fig. 6A, B). However,
calbindin-D9k levels were significantly decreased in apoptosis
induced by 1.0 to 5 mM CsA (Fig. 6C, D). This result suggests that
calbindin-D9k may be an important molecular determinant of
apoptotic or autophagic cell death by CsA in rat pituitary GH3
cells.
Discussion
CsA has been shown to induce autophagic and apoptotic cell
death in both in vivo and in vitro experiments [12–14,16,17].
These researches suggest that the relative levels of ER stress
responses may be a determinant of apoptotic cell death by
Figure 2. Effect of CsA-mediated apoptotic cell death on p53
expression levels. GH3 cells were incubated in DMEM with or without
10% fetal bovine serum in the presence or absence of CsA (0 to 10 mM)
for 10 h. p53 expression (A) was determined by Western blotting and
the relative amount (B) was calculated as described in the Materials and
Methods. *p,0.05, **p,0.01 vs. serum treatment. #p,0.05, ###p,
0.001 vs. no serum treatment.
doi:10.1371/journal.pone.0108981.g002
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depleting proapoptotic proteins. In other experiments, CsA
induced apoptosis by up-regulating the proapoptotic factors p53
and Bax, cleaving PARP, and down-regulating the antiapoptotic
factor Bcl-2 in cultured rat mesangial cells and in a rat chronic
nephrotoxicity model [22,23].
The mechanisms underlying chronic CsA nephropathy are not
completely understood. Activation of the intrarenal renin-angio-
tensin system, increased release of endothelin-1, inappropriate
apoptosis, stimulation of inflammatory mediators, and ER stress
have all been implicated in the pathogenesis of chronic CsA
nephropathy [10]. Pellet et al. [13] demonstrated that CsA induces
autophagy in primary cultured human renal tubular cells through
LC3-II expression and autophagosome visualization by electron
microscopy. CsA-induced autophagy may occur downstream of
ER stress. Various ER stresses activate autophagy, and salubrinal,
an inhibitor of eIF2alpha dephosphorylation, both protects cells
against ER stress and inhibits LC3-II expression.
The cross-talk between autophagic and apoptotic cell death
pathways is complex [4,5]. Three different types of interaction
between these pathways have been postulated: (1) an apoptosis/
autophagy partnership; (2) autophagy may antagonize apoptosis;
or (3) autophagy may enable apoptosis. We demonstrated that
CsA treatment increased nuclear fragmentation and Bax-2 levels,
and reduced Bcl-2, resulting in apoptotic cell death. Translocation
of Bcl-2 family members from the cytoplasm to the mitochondria
is a central step in propagation of apoptotic signals to the
cytoplasm [24–26]. In contrast, Bcl-2 levels increased during
autophagic cell death. This result suggests that autophagy may act
to interfere or to attenuate apoptosis and participate in cell
protection. Autophagy was shown to be essential for survival
during nutrient starvation in vivo and in vitro [27–30]. Autophagy
also protected epithelial cells from apoptotic cell death [31] during
metabolic stress [32], drug treatment, and radiation damage for
genotoxic ROS [33].
Our data demonstrate that CsA activates p53 and triggers
apoptotic cell death in GH3 cells. These data are consistent with
other reports, which showed CsA treatment activates p53, induces
nuclear localization, and activates the expression of the p53 target
genes Bax, mdm2, and p21waf1 [24]. Importantly, inhibition of
endogenous p53 or lack of functional p53 significantly reduces the
extent of CsA-induced apoptosis, indicating that p53 is critical for
CsA-mediated cell death. Our data show that an immunosup-
pressive drug is capable of activating p53 in GH3 cells.
Although a direct link between CsA-mediated ROS generation
and adverse renal toxicity in rat renal tubular cells has not been
demonstrated [34], it has been suggested that increased ROS
levels may contribute to adverse CsA side effects [35,36]. CsA-
induced ROS generation and susceptibility to ROS are highly
tissue-specific [37]. Autophagy is also regulated by ROS, including
superoxide and hydrogen peroxide, though superoxide may be the
central ROS that regulates autophagy [38,39]. To examine the
role of ROS in CsA mediated cell death, we examined ERK and
SOD protein levels, components of the pathways that are activated
in response to oxidative stress [40]. In addition, both phospho-
inositide 3-kinase/protein kinase B (PI3K/PKB) and ERK
pathways have been implicated in survival and death responses
of mouse kidney cells [41]. CsA treatment of GH3 cells reduced
Cu/Zn-SOD expression in autophagy (Fig. 5A, B) and Mn-SOD
expression in apoptosis in a dose dependent fashion (Fig. 5D, F).
These results suggest that the changes in Cu/Zn- and Mn-SOD
expression are associated with apoptotic and autophagic cell death
by CsA treatment in GH3 cells.
The ER appears to function as a key initiator or a regulator of
apoptosis with Ca2+-mediated signaling [19,42], An increase in
Figure 3. Effect of CsA-mediated autophagic and apoptotic cell death on p-ERK levels. GH3 cells were incubated in DMEM with or without
10% fetal bovine serum in the presence or absence of CsA (0 to 10 mM) for 10 h. Levels of p-ERK for autophagy (A) and apoptosis (C) were determined
by Western blotting and the relative amount of p-ERK for autophagy (B) and apoptosis (D) was calculated as described in the Materials and Methods.
***p,0.01 vs. serum treatment. ##p,0.01, ###p,0.001 vs. no serum treatment.
doi:10.1371/journal.pone.0108981.g003
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mitochondrial matrix Ca2+ regulates metabolism, and Ca2+ also
modulates mitochondrial permeability transition, which is con-
trolled by permeability transition pores [43]. Permeability
transition pores have been implicated in apoptotic, autophagic,
and necrotic cell death pathways. We examined calbindin-D9k
levels indirectly as a marker for intracellular Ca2+ modulation.
Calbindin-D9k is expressed in the mammalian intestine (duode-
num), kidney, pituitary gland, growth cartilage, bone, and female
reproductive tissues [44–47]. Uterine calbindin-D9k has been
shown to be involved in the regulation of myometrial activity by
intracellular calcium [48]. Our results suggest that calbindin-D9k
may act as an important intracellular calcium ion exchanger that
regulates apoptotic or autophagic cell death by CsA in rat pituitary
GH3 cells.
In summary, we found that CsA induces apoptotic and
autophagic cell death in rat pituitary GH3 cells. Apoptotic and
autophagic cell death could be distinguished both morphologically




Rat pituitary GH3 cells, which originated from the growth
hormone-producing tumor of the rat anterior pituitary and
somatomammotroph phenotype, were purchased from ATCC
(CCL-82.1) and were cultured in Dulbecco’s modified Eagle’s
medium (DMEM, GibcoBRL, Gaithersburg, MD, USA) supple-
mented with or without 10% heat-inactivated fetal bovine serum
(GibcoBRL) at 37uC in 5% CO2 in a humidified atmosphere.
Cells were treated with CsA (0 to 100 mM) in serum-free medium.
For autophagy studies, culture dishes were coated with poly-
ethyleneimine (20 mg/mL) (Sigma, St. Louis, MO, USA), washed
with distilled water, and dried.
Cell viability assays
Cell survival was quantified using Cell Counting Kit-8 (Dojindo
Laboratories, Tokyo, Japan). In brief, GH3 cells were cultured in
96-well plates (Corning Inc., Corning, NY, USA) at a density of
56103 cells per well. The cells were cultured in the presence or
absence of melatonin. After 15 h, cells were washed, treated with
Cell Counting Kit-8 reagents, incubated in the dark for 4 h, and
then absorbance (450 nm) was measured using a plate reader
(Molecular Device, Sunnyvale, CA). Percent viability was calcu-
lated as the absorbance of the melatonin-treated sample/control
absorbance6100.
Western blot analysis
Cells were harvested, washed two times with ice-cold PBS, and
then resuspended in 20 mM Tris-HCl buffer (pH 7.4) containing a
protease inhibitor mixture (0.1 mM phenylmethylsulfonyl fluoride,
5 mg/mL aprotinin, 5 mg/mL pepstatin A, 1 mg/mL chymostatin)
and phosphatase inhibitors (5 mM Na3VO4, 5 mM NaF). Whole
cell lysates were prepared with a Dounce homogenizer (20 strokes),
followed by centrifugation at 13,0006g for 20 min at 4uC. Protein
concentration was determined using a BCA assay (Sigma). Proteins
(50 mg) were separated by 12% SDS-PAGE and then transferred
onto polyvinylidene difluoride (PVDF) membranes. Membranes
were hybridized with antibodies specific for LC3 (Santa Cruz
Biotechnology, Santa Cruz, CA, USA), p53 (Santa Cruz Biotech-
nology), Cu/Zn- and Mn-SOD (Cell Signaling Technology,
Beverly, MA, USA), p-ERK and ERK (Transduction Laboratories,
Lexington, KY, USA), Bax and Bcl-2 (Santa Cruz Biotechnology),
calbindin-D9k (Swant, Bellinzona, Switzerland), and GAPDH
(Assay Designs, Ann Arbor, MI, USA). Immunoreactive proteins
were visualized by exposure of the membrane to X-ray film. The
films were scanned and the band intensities and optical densities
were corrected by background subtraction, quantified using ImageJ
analysis software (version 1.52, Wayne Rasband, NIH, Bethesda,
MD, USA), and then normalized.
Immunofluorescence staining
GH3 cells grown on culture slides (BD Falcon Labware, REF
354108) were permeabilized and fixed in methanol at 220uC for
3 min. Cells were washed with phosphate-buffered saline (PBS),
blocked with 10% bovine serum albumin (Sigma) with PBS for
10 min, and incubated with primary antibody in blocking buffer
for 1 h at room temperature (RT). Cells were hybridized with
secondary antibodies for 1 h at RT. The coverslips were mounted
on glass slides using Vectashield mounting medium (Vector Labs
Inc., Burlingame, CA, USA). Cells were viewed under a Leica
TCS SP5 confocal microscope (Leica, Microsystems CMS GmbH,
Germany). The following primary antibodies were used: Lamp2
(Cell Signaling Technology) and LC3 (Cell Signaling Technology).
The following secondary antibodies were used: Alexa 594 (red)-
conjugated anti-rabbit IgG (Vector Laboratories Inc.) and
fluorescein isothiocyanate (green)-labeled anti-mouse IgG (Jackson
ImmunoResearch Laboratories, West Grove, PA, USA).
Nuclear staining and immunofluorescence microscopy
Cells were fixed in 4% paraformaldehyde buffered with 0.1 M
phosphate (pH 7.3) for 30 min and then washed with phosphate-
buffered saline (PBS). Cells were permeabilized with 0.3% Triton
X-100 for 20 min, washed with PBS, and then stained with 4,6-
diamidino-2-phenylindole (DAPI, Santa Cruz, USA) for 10 min.
For immunofluorescence microscopy, GH3 cells were grown on
culture slides (Nunclon, Gibco cat. no. 176740, NV Invitrogen
SA, Merelbeke, Belgium) and then fixed in cold methanol for
10 min at 20uC. Cells were washed in PBS, blocked with 5%
bovine serum albumin in PBS for 30 min, and incubated with
primary antibody (Bcl-2, Santa Cruz Biotechnology) in 2% bovine
serum albumin (BSA) for 1 h at room temperature. Cells were
washed with PBS and subsequently incubated with secondary
antibody (fluorescein isothiocyanate (green)-labeled anti-mouse
IgG (Jackson ImmunoResearch Laboratories) in 2% BSA for 1 h
at room temperature. After washing with PBS, images were
acquired at a peak excitation wavelength of 340 nm (Olympu-
sIX71) using an OLYMPUS DP controller and manager (2006
magnification).
DNA fragmentation analysis
Cell pellets were resuspended in 750 mL of lysis buffer (20 mm
Tris-HCl, 10 mm EDTA, and 0.5% Triton X-100, pH 8.0) and
left on ice for 45 min with occasional shaking. DNA was extracted
Figure 4. Effect of CsA-mediated autophagic and apoptotic cell death on Bax and Bcl-2 levels. GH3 cells were incubated in DMEM with or
without 10% fetal bovine serum in the presence or absence of CsA (0 to 10 mM) for 10 h. Levels of Bax and Bcl-2 for autophagy (A) and apoptosis (E)
were determined by Western blotting and the relative amount of Bax and Bcl-2 for autophagy (B, C) and apoptosis (F, G) was calculated as described
in the Materials and Methods. Bcl-2 was imaged on an OLYMPUS DP controller and manager using an inverted microscope (D). *p,0.05, **p,0.01,
***p,0.001 vs. serum treatment. #p,0.05, ###p,0.001 vs. no serum treatment. Scale bar is 100 mm.
doi:10.1371/journal.pone.0108981.g004
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Figure 5. Effect of CsA-mediated autophagic and apoptotic death on Cu/Zn- and Mn-SOD levels. GH3 cells were incubated in DMEM
with or without 10% fetal bovine serum in the presence or absence of CsA (0 to 10 mM) for 10 h. Cu/Zn- and Mn-SOD levels for autophagy (A) and
apoptosis (D) were determined by Western blotting and the relative amount for autophagy (B, C) and apoptosis (E, F) was calculated as described in
the Materials and Methods. *p,0.05, ***p,0.001 vs. serum treatment. ###p,0.001 vs. no serum treatment.
doi:10.1371/journal.pone.0108981.g005
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with phenol/chloroform and precipitated with alcohol. The
precipitate was dried and resuspended in 100 mL of 20 mM
Tris-HCl, pH 8.0. After degradation of RNA with RNase
(0.1 mg/mL) at 37uC for 1 h, samples (15 mL) were electropho-
resed on a 1.2% agarose gel in 450 mM Tris borate-EDTA buffer
(TBE, pH 8.0) and photographed under UV light.
Statistical analysis
Significant differences were detected by ANOVA, followed by
Tukey’s test for multiple comparisons. Analysis was performed
using the Prism Graph Pad v4.0 (Graph Pad Software Inc., San
Diego, CA, USA). Values are expressed as means 6 SD of at least
three separated experiments, in which case a representative
experiment is depicted in the figures. P values,0.05 were
considered statistically significant.
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